ABOUT GEORGE SIBER, MD
Dr. Siber is an infectious disease trained physician with 40 years’ experience in developing vaccines and antibody products. From 1996 to 2007, Dr. Siber served as Executive Vice President and Chief Scientific Officer of Wyeth Vaccines (now Pfizer) where he led the development and approval of multiple innovative childhood vaccines, including Prevenar7 and 13, the first pneumococcal conjugate vaccines, Rotashield, the first rotavirus diarrhea vaccine, Meningitec, the first meningococcal meningitis conjugate vaccine and FluMist, the first nasal influenza vaccine.
ABOUT TOM MONATH, MD
Tom is currently Managing Partner and Chief Scientist of Crozet BioPharma LLC, a biopharmaceutical company working on vaccines against Marburg and Nipah viruses with funding from BARDA and CEPI. He was formerly CSO and COO of the ID Division of NewLink Genetics, where he led development of the most advanced Ebola virus vaccine in partnership with Merck.
Tom has over 25 years’ experience in the biotechnology industry, including as CSO and Executive Director of Acambis prior to its acquisition by Sanofi Pasteur, where he directed R&D on vaccines against dengue, Japanese encephalitis, West Nile, yellow fever, Clostridium difficile, and smallpox, three of which are now licensed products.
ABOUT WAYNE KOFF, PhD
Wayne Koff, Ph.D., is the founding President and CEO of the Human Vaccines Project, a non-profit R&D consortium focused on decoding the human immune system to accelerate vaccine and therapeutic development. In 2019, Dr. Koff was named by Foreign Policy along with Barack and Michelle Obama, Bill and Melinda Gates, Angela Merkel, and others as one of the 100 Global Thinkers who have “ had a profound impact on the planet in the last 12 months.” As of July 2020, Dr. Koff is also Adjunct Professor, Dept. of Epidemiology, Harvard TH Chan School of Public Health.
ABOUT TONY ROBBINS
Tony Robbins is an entrepreneur, best-selling author, philanthropist, and the world's #1 life and business strategist. For over 4 decades, more than 50 million people have enjoyed the warmth, humor, and transformational power of his business and personal development events. He is the nation’s #1 life and business strategist. Mr. Robbins is the chairman of a holding company comprised of 40 privately held businesses with combined sales exceeding $5 billion a year.
ABOUT PETER H. DIAMANDIS
Peter H. Diamandis is the Executive Founder of Singularity University and Executive Chairman of the XPRIZE Foundation. In 2014 he was named one of "The World’s 50 Greatest Leaders" – by Fortune Magazine. Diamandis is the New York Times Bestselling author of Abundance and BOLD. He earned an undergraduate degree in Molecular Genetics and a graduate degree in Aerospace Engineering from MIT, and received his M.D. from Harvard Medical School.
